COP vs DHR: Which Is the Better Buy?
Side-by-side comparison of ConocoPhillips and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
ConocoPhillips · Energy
$107.74
-21.3% upside to fair value
Grade D
High Quality
VS
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+8.9%).
COP trades at a lower forward P/E
(18.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
COP |
DHR |
| Current Price |
$107.74 |
$177.17 |
| Fair Value Estimate |
$84.75 |
$192.90 |
| Upside to Fair Value |
-21.3%
|
+8.9%
|
| Market Cap |
$131.3B |
$125.4B |
| Forward P/E |
18.3x
|
34.1x
|
| EV / EBITDA |
6.1x
|
20.8x
|
| Price / Sales |
2.2x
|
5.1x
|
| Price / FCF |
8.5x
|
23.7x
|
| Revenue Growth YoY |
-2.5%
|
+3.7%
|
| Gross Margin |
29.2%
|
60.7%
|
| Operating Margin |
18.3%
|
21.0%
|
| Return on Equity |
11.3%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
11.72%
|
4.22%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
ConocoPhillips is a leading global oil and gas exploration and production company with a strong competitive position as the largest producer in Alaska and a top-five international producer following recent acquisitions. The company benefits from a durable moat supported by scale advantages, a broad international footprint, and a shareholder-focused capital allocation strategy under CEO Ryan Lance…
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Accumulation Zones
| Metric |
COP |
DHR |
| Zone Low |
$63.56 |
$144.68 |
| Zone High |
$72.04 |
$163.97 |
| In Buy Zone? |
No
|
No
|